ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
610 hedge funds and large institutions have $29.1B invested in Alexion Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 85 funds opening new positions, 263 increasing their positions, 191 reducing their positions, and 75 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding
Funds holding: 608 → 610 (+2)
11% less call options, than puts
Call options by funds: $196M | Put options by funds: $221M
Holders
610
Holding in Top 10
12
Calls
$196M
Puts
$221M
Top Buyers
| 1 | +$395M | |
| 2 | +$371M | |
| 3 | +$204M | |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
+$189M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$141M |
Top Sellers
| 1 | -$475M | |
| 2 | -$269M | |
| 3 | -$151M | |
| 4 |
D.E. Shaw & Co
New York
|
-$93.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$75M |